Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,250 | -554,128 | -364,811 | -168,312 | -17,492 |
| Depreciation Amortization | 8,930 | 26,911 | 19,623 | 11,076 | 5,245 |
| Accounts receivable | -16,863 | -10,461 | -30,948 | -13,149 | -15,996 |
| Other Working Capital | -57,287 | 554,056 | 586,465 | 717,046 | 716,968 |
| Other Operating Activity | 52,099 | 91,088 | 71,672 | -26,474 | -60,935 |
| Operating Cash Flow | $-180,371 | $107,466 | $282,001 | $520,187 | $627,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 180,011 | -144,088 | -49,711 | -129,758 | -115,437 |
| PPE Investments | -21,149 | -82,202 | -53,592 | -28,289 | -9,120 |
| Purchase Sale Intangibles | N/A | 108,069 | 108,069 | 108,069 | 108,069 |
| Other Investing Activity | -2,196 | 104,569 | 105,473 | 106,142 | 106,877 |
| Investing Cash Flow | $156,666 | $-121,721 | $2,170 | $-51,905 | $-17,680 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 291,150 | N/A | N/A | N/A |
| Common Stock Issued | 9,226 | 396,010 | 360,184 | 341,395 | 323,820 |
| Other Financing Activity | -6,333 | -4,837 | -4,798 | -4,798 | -4,798 |
| Financing Cash Flow | $2,893 | $682,323 | $355,386 | $336,597 | $319,022 |
| Beginning Cash Position | 1,511,713 | 843,645 | 843,645 | 843,645 | 843,645 |
| End Cash Position | 1,490,901 | 1,511,713 | 1,483,202 | 1,648,524 | 1,772,777 |
| Net Cash Flow | $-20,812 | $668,068 | $639,557 | $804,879 | $929,132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180,371 | 107,466 | 282,001 | 520,187 | 627,790 |
| Capital Expenditure | -21,149 | -82,202 | -53,592 | -28,289 | -9,120 |
| Free Cash Flow | -201,520 | 25,264 | 228,409 | 491,898 | 618,670 |